Overexpression of AKR1B10 predicts tumor recurrence and short survival in oral squamous cell carcinoma patients.

Chih-Yeu FangYun-Ho LinChi-Long Chen

Published in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2019)

We validated and expanded data on the expression of AKR1B10 in OSCC, suggesting that it is a valuable biomarker for prognostic prediction of recurrence and survival in OSCC.

Keyphrases

free survival
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
poor prognosis
cell proliferation
prognostic factors
transcription factor
long non coding rna
machine learning
binding protein
patient reported outcomes